Septerna (SEPN) Change in Acquisitions & Divestments (2024 - 2026)
Septerna's (SEPN) quarterly Change in Acquisitions & Divestments came in at $82.2 million in Q1 2026, up 81.87% year-on-year from $45.2 million in Q1 2025, and up 94.89% quarter-over-quarter from $42.2 million in Q4 2025.
Septerna (SEPN) Change in Acquisitions & Divestments (2024 - 2026) Analysis & Trends
Septerna's Change in Acquisitions & Divestments history runs 3 years deep, the most recent figure standing at $82.2 million for Q1 2026.
- On a quarterly basis, Change in Acquisitions & Divestments rose 81.87% year-over-year to $82.2 million in Q1 2026; TTM through Mar 2026 was $246.6 million, a 218.27% increase from a year earlier, with the FY2025 full-year figure at $209.6 million, up 549.57% from the prior year.
- Change in Acquisitions & Divestments rose to $82.2 million in Q1 2026 per SEPN's latest filing, from $42.2 million in the prior quarter.
- Across five years, Change in Acquisitions & Divestments topped out at $82.2 million in Q1 2026 and bottomed at $7.9 million in Q2 2024.
- The 3-year median for Change in Acquisitions & Divestments is $43.7 million (2025), against an average of $40.5 million.
- Across the five-year window, Change in Acquisitions & Divestments jumped 697.94% in 2025 and jumped 81.87% in 2026, its largest moves.
- Year by year, Change in Acquisitions & Divestments stood at $14.9 million in 2024, then surged by 182.56% to $42.2 million in 2025, then soared by 94.89% to $82.2 million in 2026.
- Per Business Quant, the three latest SEPN Change in Acquisitions & Divestments figures stand at $82.2 million (Q1 2026), $42.2 million (Q4 2025), and $59.1 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,681.27 Bn | 66,680.98 Bn | - |
| 2 | Nanobiotix | 1,911.83 Bn | 1,911.77 Bn | - |
| 3 | Akari Therapeutics | 959.56 Bn | 959.56 Bn | - |
| 4 | BeOne Medicines | 472.75 Bn | 467.96 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 122.14 Bn | 114.89 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 70.09 Bn | 61.34 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.34 Bn | 62.34 Bn | - |
| 8 | Argenx Se | 55.94 Bn | 50.76 Bn | 1.41 Bn |
| 9 | Alnylam Pharmaceuticals | 37.52 Bn | 34.51 Bn | 959.66 Mn |
| 10 | Septerna | 1.50 Bn | 1.50 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 82.25 Mn |
| Mar 31, 2026 | 82.25 Mn |
| Dec 31, 2025 | 42.20 Mn |
| Dec 31, 2025 | 42.20 Mn |
| Sep 30, 2025 | 59.08 Mn |
| Sep 30, 2025 | 59.08 Mn |
| Jun 30, 2025 | 63.12 Mn |
| Jun 30, 2025 | 63.12 Mn |
| Mar 31, 2025 | 45.22 Mn |
| Mar 31, 2025 | 45.22 Mn |
| Dec 31, 2024 | 14.94 Mn |
| Dec 31, 2024 | 14.94 Mn |
| Sep 30, 2024 | 9.43 Mn |
| Sep 30, 2024 | 9.43 Mn |
| Jun 30, 2024 | 7.91 Mn |
| Jun 30, 2024 | 7.91 Mn |